Cover Image
市場調查報告書

全球經導管治療市場預測

Global Transcatheter Market Outlook 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 352579
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
全球經導管治療市場預測 Global Transcatheter Market Outlook 2020
出版日期: 2016年02月01日 內容資訊: 英文 75 Pages
簡介

全球經導管心臟瓣膜置換市場,2015年達到了18億美元規模。市場上,經導管主動脈瓣置換 (TAVR) 最大的市場佔有率。

本報告提供全球經導管心臟瓣膜置換市場相關調查分析,市場現況與展望,主要推動因素與課題,趨勢與發展,競爭情形等系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 經導管心臟瓣膜置換:簡介

  • 心臟瓣膜的種類
  • 心臟瓣膜疾病

第4章 市場動態

  • 推動因素
  • 課題
  • 機會

第5章 全球經導管心臟瓣膜置換市場預測

  • 目前市場規模與未來成長

第6章 經導管心臟瓣膜置換市場:心臟瓣膜的各類型

  • 簡介
    • 經導管主動脈瓣置換 (TAVR)
    • 經導管肺動脈瓣置換 (TPVR)

第7章 經導管心臟瓣膜置換市場:各途徑

  • 簡介
    • 經大腿
    • 經心尖

第8章 經導管心臟瓣膜置換市場:各地區

  • 簡介
    • 北美
    • 歐洲
    • 亞洲

第9章 開發平台分析

  • 美國
  • 歐洲

第10章 波特的五力分析

第11章 競爭分析

  • 市場佔有率評估

第12章 主要企業分析

  • Boston Scientific Corporation
  • Direct Flow Medical, Inc.
  • Edward Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Medtronic plc
  • St. Jude Medical, Inc.
  • Symetis SA

圖表

目錄

The ever increasing rise in the cardiovascular diseases, especially the valvular diseases, has led to the discovery of innovative treatment techniques. One of the recent technological innovations include the transcatheter heart valve replacement, which involves delivering the new replacement valves without removing the diseased valve via a catheter. This newly developed procedure thus eliminates the need of an open heart surgery. The technique has emerged to prove extremely beneficial for patients with high risk for the traditional open heart surgery. The success of these innovative techniques has garnered interest from major medical devices players from across the globe.

According to a new analysis from RNCOS in "Global Transcatheter Market Outlook 2020" report, the Global Transcatheter Heart Valve Replacement Market is valued at around US$ 1.8 Billion in 2015. The evolving market size could be attributed to factors such as rising incidences of valvular heart diseases, the increasing adoption of transcatheter aortic valve replacement as an alternate to the traditional open heart surgery, and the overall improving reimbursement scenario for this new procedure.

The report segments the market based on the types of transcatheter heart valves. The transcatheter aortic valve replacement accounted for the largest share in 2015. This high share of the market is attributed to large number of transcatheter aortic procedures in the US and Europe. Also, in terms of the route of delivery, the Transfemoral approach is the most preferred one, owing to the lower mortality rate and shorter recovery time.

In terms of geography, Europe is the largest market for the transcatheter heart valve replacement market. The large share of the European market is due less stringent regulatory environment in the region, which allows faster approval and commercialization of products in Europe as compared to other regions. However, it is the US market, which is expected to witness the highest growth, largely due to increasing regulatory approvals for the transcatheter heart valves, in addition to the increasing awareness of the technologically advanced technique. The report provides information on the current scenario, market outlook on the basis of the products available, application and geography, and the future forecasts on all prominent segments of the industry till 2020. Moreover, the report also provides information about the regulatory landscapes prevailing in different regions. The number of procedures performed for transcatheter aortic valve replacement is also analyzed in the report.

The report also provides details about the pipeline analysis of the various transcatheter heart valves, which are currently in the process of getting regulatory approvals in the US and Europe. The later part of the report focuses on competitive analysis of the key market players, in terms of their market share and their product offerings. Major players operating in this market include Edwards Lifesciences, Medtronic, St. Jude, amongst others. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player's business model, the player's current and historical financials have been analyzed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends which will likely generate key interest in investors thinking about joining the industry.

Table of Contents

1. Analyst View

2. Research Methodology

3. Transcatheter Heart Valve Replacement - An Introduction

  • 3.1 Types of Heart Valves
  • 3.2 Heart Valve Diseases

4. Market Dynamics

  • 4.1 Drivers
    • 4.1.1 Rising Incidence of Valvular Heart Diseases
    • 4.1.2 Increasing Adoption of Minimally Invasive Procedures
    • 4.1.3 Favourable Reimbursement Scenario
    • 4.1.4 Increasing Number of Transcatheter Aortic Valve Replacement Procedures
  • 4.2 Challenges
    • 4.2.1 Varied Stringency of Regulatory Procedures Delays Product Launches
    • 4.2.2 Associated Risks with Transcatheter Aortic Valve Replacement
  • 4.3 Opportunities
    • 4.3.1 Increasing Focus on Transcatheter Mitral Valve Replacement
    • 4.3.2 Expansion of Transcatheter Aortic Valve Replacement to Low and Intermediate Risk Patients

5. Global Transcatheter Heart Valve Replacement Market Outlook 2020

  • 5.1 Current Market Size and Future Growth

6. Transcatheter Heart Valve Replacement Market, By Valve Type

  • 6.1 Introduction
    • 6.1.1 Transcatheter Aortic Valve Replacement
    • 6.1.2 Transcatheter Pulmonary Valve Replacement

7. Transcatheter Heart Valve Replacement Market, By Delivery Route

  • 7.1 Introduction
    • 7.1.1 Transfemoral
    • 7.1.2 Transapical

8. Transcatheter Heart Valve Replacement Market, By Region

  • 8.1 Introduction
    • 8.1.1 North America
      • 8.1.1.1 Regulatory Landscape
    • 8.1.2 Europe
      • 8.1.2.1 Regulatory Landscape
    • 8.1.3 Asia
    • 8.1.3.1 Regulatory Landscape

9. Pipeline Analysis

  • 9.1 US - Pipiline Analysis
  • 9.2 Europe - Pipeline Analysis

10. Porter's Five Forces Analysis

11. Competitive Analysis

  • 11.1 Market Share Assesment

12. Key Player Analysis

  • 12.1 Boston Scientific Corporation
  • 12.2 Direct Flow Medical, Inc.
  • 12.3 Edward Lifesciences Corporation
  • 12.4 JenaValve Technology, Inc.
  • 12.5 Medtronic plc
  • 12.6 St. Jude Medical, Inc.
  • 12.7 Symetis SA

List of Figures:

  • Figure 5-1: Global - Transcatheter Heart Valve Replacement Market (Million US$), 2015-2020
  • Figure 6-1: Global - Transcatheter Heart Valve Replacement Market by Valve Type (%), 2015
  • Figure 6-2: Global - Transcatheter Aortic Valve Replacement Market (Million US$), 2015-2020
  • Figure 6-3: Global - Transcatheter Pulmonary Valve Replacement Market (Million US$), 2015-2020
  • Figure 7-1: Global - Transcatheter Heart Valve Replacement Market by Delivery Route (%), 2015
  • Figure 7-2: Global - Transcatheter Heart Valve Replacement Market via Transfemoral Route (Million US$), 2015-2020
  • Figure 7-3: Global - Transcatheter Heart Valve Replacement Market via Transapical Route (Million US$), 2015-2020
  • Figure 8-1: Global - Transcatheter Heart Valve Replacement Market by Region (%), 2015
  • Figure 8-2: North America - Transcatheter Heart Valve Replacement Market (Million US$), 2015-2020
  • Figure 8-3: US - TAVR Procedures ('000), 2010-2015
  • Figure 8-4: Europe - Transcatheter Heart Valve Replacement Market (Million US$), 2015-2020
  • Figure 8-5: Europe - TAVR Procedures ('000), 2010-2015
  • Figure 8-6: Asia - Transcatheter Heart Valve Replacement Market (Million US$), 2015-2020 42
  • Figure 8-7: Asia - TAVR Procedures, By Country, 2014
  • Figure 10-1: Porter's Five Forces Analysis
  • Figure 11-1: Global - Market Share Assesment for Key Players (%)
  • Figure 12-1: Boston Scientific Corporation - Break up of Revenue by Business Segments (%), 2014
  • Figure 12-2: Edward Lifesciences Corporation - Break up of Revenue by Product Group (%), 2014
  • Figure 12-3: Medtronic PLC - Break up of Revenue by Operating Segments (%), 2015
  • Figure 12-4: St. Jude Medical, Inc. - Break up of Revenue by Product Group (%), 2014

List of Tables:

  • Table 6-1: Global - Transcatheter Heart Valve Replacement Market by Valve Type(Million US$), 2015
  • Table 7-1: Global - Transcatheter Heart Valve Replacement Market by Delivery Route (Million US$), 2015
  • Table 8-1: Global - Transcatheter Heart Valve Replacement Market by Region (Million US$), 2015
  • Table 12-1: Boston Scientific Corporation - Key Financials (Million US$), 2012-2014
  • Table 12-2: Boston Scientific Corporation - Product Portfolio for Transcatheter Heart Valve
  • Table 12-3: Direct Flow Medical, Inc. - Product Portfolio for Transcatheter Heart Valve
  • Table 12-4: Edward Lifesciences Corporation - Key Financials (Million US$), 2012-2014
  • Table 12-5: Edward Lifesciences Corporation - Product Portfolio for Transcatheter Heart Valve
  • Table 12-6: JenaValve Technology, Inc. - Product Portfolio for Transcatheter Heart Valve
  • Table 12-7: Medtronic plc - Key Financials (Million US$), 2013-2015
  • Table 12-8: Medtronic plc - Product Portfolio for Transcatheter Heart Valve
  • Table 12-9: St. Jude Medical, Inc. - Key Financials (Million US$), 2012-2014
  • Table 12-10: St. Jude Medical, Inc. - Product Portfolio for Transcatheter Heart Valve
  • Table 12-11: Symestis SA - Product Portfolio for Transcatheter Heart Valve
Back to Top